Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-07T20:46:52.780Z Has data issue: false hasContentIssue false

Mapping Psychosocial Disability in Schizophrenia: Network Analysis of a Relatives-Rated Clinical Scale

Published online by Cambridge University Press:  31 July 2026

S. Frileux*
Affiliation:
UVSQ, Montigny le Bretonneux
N. Vidal
Affiliation:
CESP, Villejuif
E. Brunet
Affiliation:
Versailles Hospital, Le Chesnay, France
P. Roux
Affiliation:
UVSQ, Montigny le Bretonneux
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Schizophrenia is marked by major impairments in psychosocial functioning. Disability arises from intertwined processes, notably impairments in cognition, motivation, social interactions, and metacognition. The Evaluation of Cognitive Processes involved in Disability in Schizophrenia (ECPDS) is a 13-item scale completed by relatives, focusing on these four processes in daily life. Network analysis provides a framework to examine their interconnections, identify central nodes as potential intervention targets and explore links with external factors.

Objectives

We tested whether clustering from a network analysis of the ECPDS provides insights beyond its established four-factor structure, identifies items associated with neurocognition, global functioning, quality of life and anticholinergic burden, in order to define intervention targets to guide innovative approaches for psychosocial disability in schizophrenia.

Methods

Data came from the FondaMental FACE-SZ cohort, including patients with schizophrenia spectrum disorders; after exclusions, analyses focused on 429. Networks were estimated as regularized partial correlation networks (EBICglasso), with edge and centrality stability assessed via bootstrapping. External variables were a global neurocognition score, the Personal and Social Performance scale (PSP, a clinician-rated measure of overall psychosocial functioning in domains conceptually distinct from the ECPDS, which captures relatives’ perspectives on underlying cognitive and motivational processes), the Subjective Quality of Life scale (SQOL), and the Salahudeen anticholinergic burden scale.

Results

Three clusters emerged in the ECPDS network (image 1): (1) Cognitive Impairments, (2) Avolition, (3) Socio-Metacognitive Deficits. Strongest ECPDS nodes were “Routine organization”, “Adaptation”, “Curiosity”, and “Perspective-taking”. Neurocognition was linked with “Routine organization”, “Non-routine organization”, and “Learning”. PSP connected with “Initiative”, “Project”, and “Use of time” (image 2). For SQOL, only “Use of time” showed a reliable association(image 3). Salahudeen scale related to “Organization”, “Adaptation”, “Learning”, and “Attention”. Bootstrap analyses confirmed stability of centrality estimates.Image 1:

A network diagram showing interconnected nodes representing psychological or behavioral traits, grouped by color with varying line thicknesses. See long description.Image 2:

A network diagram showing connections between a central P S P node and various numbered nodes categorized by color. See long description.Image 3:

A network diagram showing connections between a central S Q O L node and various peripheral nodes of different colors. See long description.

Conclusions

Relatives’ assessments with the ECPDS provide specific insights into psychosocial disability. Difficulties in “organization” and “learning”, when reported by relatives, may help detect patients needing extended neuropsychological assessment. ECPDS scores may also reflect treatment effects, improving with adequate dosing but impaired by anticholinergic burden. Neurocognition, psychosocial functioning and quality of life each captured different aspects, underlining the composite nature of the ECPDS and its potential to guide targeted interventions, with consequences for cognition, functioning, and quality of life.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.